142 related articles for article (PubMed ID: 10048648)
1. Delayed contact hypersensitivity to non-steroidal anti-inflammatory drugs.
Gniazdowska B; Ruëff F; Przybilla B
Contact Dermatitis; 1999 Feb; 40(2):63-5. PubMed ID: 10048648
[TBL] [Abstract][Full Text] [Related]
2. Allergic contact dermatitis to topical preparations of bufexamac.
Pan Y; Nixon R
Australas J Dermatol; 2012 Aug; 53(3):207-10. PubMed ID: 22881467
[TBL] [Abstract][Full Text] [Related]
3. Bufexamac and diclofenac: frequency of contact sensitization and absence of cross-reactions.
Barbaud A; Tréchot P; Aublet-Cuvelier A; Reichert-Penetrat S; Schmutz JL
Contact Dermatitis; 1998 Nov; 39(5):272-3. PubMed ID: 9840280
[No Abstract] [Full Text] [Related]
4. [A common and insidious side-effect: allergic contact dermatitis caused by bufexamac used in the treatment of dermatitis. Results from the Information Network of Departments of Dermatology (IDVK)].
Schnuch A; Gefeller O; Uter W
Dtsch Med Wochenschr; 2005 Dec; 130(50):2881-6. PubMed ID: 16342011
[TBL] [Abstract][Full Text] [Related]
5. Allergic contact dermatitis with spreading over extensive regions due to topical use of 5% bufexamac ointment.
Arikawa J; Okabe S; Kaneko T
J Dermatol; 2004 Feb; 31(2):136-8. PubMed ID: 15160871
[No Abstract] [Full Text] [Related]
6. Epidemiological significance of bufexamac as a frequent and relevant contact sensitizer.
Kränke B; Szolar-Platzer C; Komericki P; Derhaschnig J; Aberer W
Contact Dermatitis; 1997 Apr; 36(4):212-5. PubMed ID: 9165205
[TBL] [Abstract][Full Text] [Related]
7. Acute generalized exanthematous pustulosis induced by bufexamac in an atopic girl.
Belhadjali H; Ghannouchi N; Njim L; Mohamed M; Moussa A; Bayou F; Chakroun M; Zakhama A; Zili J
Contact Dermatitis; 2008 Apr; 58(4):247-8. PubMed ID: 18353041
[No Abstract] [Full Text] [Related]
8. Allergic contact dermatitis syndrome from bufexamac for nursing infant.
Nakada T; Matsuzawa Y
Dermatitis; 2012; 23(4):185-6. PubMed ID: 22828265
[No Abstract] [Full Text] [Related]
9. [Severe allergic contact dermatitis with generalized spread due to bufexamac presenting as the "baboon" syndrome].
Proske S; Uter W; Schnuch A; Hartschuh W
Dtsch Med Wochenschr; 2003 Mar; 128(11):545-7. PubMed ID: 12635026
[TBL] [Abstract][Full Text] [Related]
10. Severe allergic contact dermatitis caused by topical bufexamac requiring hospitalization.
Wong GN; Shen S; Nixon R
Contact Dermatitis; 2019 Jun; 80(6):395-397. PubMed ID: 30624772
[No Abstract] [Full Text] [Related]
11. Severe cutaneous eruptions following the topical use of preparations containing bufexamac: Is it time to reconsider its registration in Australia?
Harris AG; Saikal SL; Scurry J; Relic J; Nixon RL; Chee P
Australas J Dermatol; 2019 Feb; 60(1):53-56. PubMed ID: 30155971
[TBL] [Abstract][Full Text] [Related]
12. [Contact allergies caused by bufexamac].
Geier J; Fuchs T
Med Klin (Munich); 1989 Jul; 84(7):333-8. PubMed ID: 2529420
[TBL] [Abstract][Full Text] [Related]
13. Multiple cutaneous sensitization to nonsteroidal anti-inflammatory drugs.
Gonzalo MA; Revenga F
Dermatology; 1996; 193(1):59-60. PubMed ID: 8864624
[TBL] [Abstract][Full Text] [Related]
14. Erythema-multiforme-like, urticarial papular and plaque eruptions from bufexamac: report of 4 cases.
Koch P; Bahmer FA
Contact Dermatitis; 1994 Aug; 31(2):97-101. PubMed ID: 7750277
[TBL] [Abstract][Full Text] [Related]
15. Allergic contact dermatitis to etofenamate. Cross-reaction to other nonsteroidal anti-inflammatory drugs.
Alcántara Villar M; Pagan JA; Palacios L; Quiralte J; Ramirez M
Contact Dermatitis; 2008 Feb; 58(2):118-9. PubMed ID: 18186756
[No Abstract] [Full Text] [Related]
16. Combined contact and photocontact allergic dermatitis to etofenamate in flogoprofen gel.
Sánchez-Pérez J; Sánchez TS; García-Díez A
Am J Contact Dermat; 2001 Dec; 12(4):215-6. PubMed ID: 11753896
[TBL] [Abstract][Full Text] [Related]
17. Contact and photocontact allergy to ketoprofen. The Belgian experience.
Matthieu L; Meuleman L; Van Hecke E; Blondeel A; Dezfoulian B; Constandt L; Goossens A
Contact Dermatitis; 2004 Apr; 50(4):238-41. PubMed ID: 15186381
[TBL] [Abstract][Full Text] [Related]
18. Allergic contact dermatitis from etofenamate without cross-sensitization to other anthranilic acid derivatives.
Chu CY; Chen YL; Lin LJ; Sun CC
Dermatology; 2003; 206(4):341-2. PubMed ID: 12771478
[No Abstract] [Full Text] [Related]
19. Contact allergy in chronic eczematous lip dermatitis.
Schena D; Fantuzzi F; Girolomoni G
Eur J Dermatol; 2008; 18(6):688-92. PubMed ID: 18955202
[TBL] [Abstract][Full Text] [Related]
20. Bufexamac is a frequent contact sensitizer.
Kränke B; Derhaschnig J; Komericki P; Aberer W
Contact Dermatitis; 1996 Jan; 34(1):63-4. PubMed ID: 8789232
[No Abstract] [Full Text] [Related]
[Next] [New Search]